GL1X · GenesisL1 explorer

Research workbench

MAPK14 with bound inhibitor sr-318

Analyse MAPK14 with bound inhibitor sr-318 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6SFO
Type
protein
Length
334 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 14
EC
2.7.11.24
UniProt
Q16539
Ligands
LBE, NA
Pockets
5 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 14 (EC 2.7.11.24)protein33437% helix, 14% strandQ16539

Ligands and binding sites

  • LBE · 5-azanyl-~{N}-[[4-(3-cyclohexylpropylcarbamoyl) phenyl]methyl]-1-phenyl-pyrazole-4-carboxamide · ligand · chains A
  • NA · Sodium ion · metal · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14510.730.8250LBE
22600.710.8623empty
3970.370.7517empty
4690.320.7518empty
5570.310.7515empty

Compared structures

  • 6SFO · MAPK14 with bound inhibitor SR-318 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.